| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Provention Bio Inc (F: 2VB)
2VB Technical Analysis
5
| As on 25th Apr 2023 2VB STOCK Price closed @ 21.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.83 & Strong Buy for SHORT-TERM with Stoploss of 5.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
2VBSTOCK Price
| Open | 21.70 | Change | Price | % |
| High | 21.70 | 1 Day | -0.84 | -3.73 |
| Low | 21.70 | 1 Week | 0.04 | 0.18 |
| Close | 21.70 | 1 Month | 14.72 | 210.89 |
| Volume | N/A | 1 Year | 15.95 | 277.39 |
| 52 Week High 22.60 | 52 Week Low 3.20 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 2VB Daily Charts |
2VB Intraday Charts |
Whats New @ Bazaartrend |
2VB Free Analysis |
|
|
2VB Important Levels Intraday
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
| RESISTANCE | 21.70 |
2VB Forecast December 2025
| 4th UP Forecast | 25.59 |
| 3rd UP Forecast | 24.34 |
| 2nd UP Forecast | 23.57 |
| 1st UP Forecast | 22.8 |
| 1st DOWN Forecast | 20.6 |
| 2nd DOWN Forecast | 19.83 |
| 3rd DOWN Forecast | 19.06 |
| 4th DOWN Forecast | 17.81 |
2VB Weekly Forecast
| 4th UP Forecast | 23.24 |
| 3rd UP Forecast | 22.75 |
| 2nd UP Forecast | 22.44 |
| 1st UP Forecast | 22.14 |
| 1st DOWN Forecast | 21.26 |
| 2nd DOWN Forecast | 20.96 |
| 3rd DOWN Forecast | 20.65 |
| 4th DOWN Forecast | 20.16 |
2VB Forecast2025
| 4th UP Forecast | 59.43 |
| 3rd UP Forecast | 47.33 |
| 2nd UP Forecast | 39.85 |
| 1st UP Forecast | 32.37 |
| 1st DOWN Forecast | 11.03 |
| 2nd DOWN Forecast | 3.55 |
| 3rd DOWN Forecast | -3.93 |
| 4th DOWN Forecast | -16.03 |
Provention Bio Inc ( F Germany Symbol : 2VB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
2VB Business Profile
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-6527, an oral CSF-1R inhibitor, which has completed Phase IIa clinical trial for the treatment of Crohn's disease; PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. The company was incorporated in 2016 and is headquartered in Red Bank, New Jersey. Address: 55 Broad Street, Red Bank, NJ, United States, 07701
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service